Literature DB >> 22975759

Informatics and clinical genome sequencing: opening the black box.

Sowmiya Moorthie1, Alison Hall, Caroline F Wright.   

Abstract

Adoption of whole-genome sequencing as a routine biomedical tool is dependent not only on the availability of new high-throughput sequencing technologies, but also on the concomitant development of methods and tools for data collection, analysis, and interpretation. It would also be enormously facilitated by the development of decision support systems for clinicians and consideration of how such information can best be incorporated into care pathways. Here we present an overview of the data analysis and interpretation pipeline, the wider informatics needs, and some of the relevant ethical and legal issues.

Entities:  

Mesh:

Year:  2012        PMID: 22975759     DOI: 10.1038/gim.2012.116

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  13 in total

1.  Development of the clinical next-generation sequencing industry in a shifting policy climate.

Authors:  Margaret A Curnutte; Karen L Frumovitz; Juli M Bollinger; Amy L McGuire; David J Kaufman
Journal:  Nat Biotechnol       Date:  2014-10       Impact factor: 54.908

Review 2.  Paediatric genomics: diagnosing rare disease in children.

Authors:  Caroline F Wright; David R FitzPatrick; Helen V Firth
Journal:  Nat Rev Genet       Date:  2018-02-05       Impact factor: 53.242

3.  How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

Authors:  Barbara J Evans; Gail Javitt; Ralph Hall; Megan Robertson; Pilar Ossorio; Susan M Wolf; Thomas Morgan; Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

4.  The nuanced negative: Meanings of a negative diagnostic result in clinical exome sequencing.

Authors:  Debra Skinner; Kelly A Raspberry; Martha King
Journal:  Sociol Health Illn       Date:  2016-08-19

5.  Clinical integration of next generation sequencing: a policy analysis.

Authors:  David Kaufman; Margaret Curnutte; Amy L McGuire
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

6.  Clinical integration of next generation sequencing: coverage and reimbursement challenges.

Authors:  Patricia A Deverka; Jennifer C Dreyfus
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

Review 7.  Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results.

Authors:  Shunchao Bao; Xinyu Wang; Mo Li; Zhao Gao; Dongdong Zheng; Dihan Shen; Linlin Liu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 8.  Stakeholder engagement: a key component of integrating genomic information into electronic health records.

Authors:  Andrea Hartzler; Catherine A McCarty; Luke V Rasmussen; Marc S Williams; Murray Brilliant; Erica A Bowton; Ellen Wright Clayton; William A Faucett; Kadija Ferryman; Julie R Field; Stephanie M Fullerton; Carol R Horowitz; Barbara A Koenig; Jennifer B McCormick; James D Ralston; Saskia C Sanderson; Maureen E Smith; Susan Brown Trinidad
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

9.  A systematic review on the genetics of male infertility in the era of next-generation sequencing.

Authors:  Amal Robay; Saleha Abbasi; Ammira Akil; Haitham El-Bardisi; Mohamed Arafa; Ronald G Crystal; Khalid A Fakhro
Journal:  Arab J Urol       Date:  2018-02-14

10.  Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities.

Authors:  Chiara Di Resta; Silvia Galbiati; Paola Carrera; Maurizio Ferrari
Journal:  EJIFCC       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.